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Heterokaryons represent a stable and reproducible model system for the study 
of biochemical nd molecular aspects responsible for muscle gene activation. 
Previous experiments have used this fusion system to demonstrate human gene 
activation in hybrids formed between human and non-human cells. The aim 
of this research was to apply this experimental model to the correction of a 
cytoplasmic activity, namely glucose-6-phosphate dehydrogenase (G6PD), in 
vitro, in hybrid myotubes formed between G6PD-negative and positive myob- 
lasts. Different identification methods were used (Hoechst stain and Fluores- 
cent Latex Microspheres, FLMs) to identify hybrid myotubes formed. We de- 
monstrated the restoration of G6PD activity in all hybrid myotubes formed; 
we then tried to elucidate the mechanisms underlying the restoration of this 
specific activity and apply the results obtained to the understanding of more 
complex mechanisms involved in muscle gene activation. 
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Introduction 
Myoblast cultures provide an advantageous sys- 
tem in which to examine biochemical and mole- 
cular changes associated with differentation be- 
cause myoblast fusion is a naturally occurring 
process. Cellular differentiation does not appear 
to be due to loss of genomic material [6, 8, 15] 
but rather, to generate and maintain the special- 
ized characteristics of cells of different issues, 
genes must be activated and repressed in a well- 
Paper presented atthe National Congress at Sorrento in 
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defined sequential pattern. An elucidation of the 
mechanisms that regulate changes in gene expres- 
sion is of central importance to an understanding 
of the generation and development of more com- 
plex cellular systems. When cells of two different 
species are fused together, either spontaneously or
by PEG-induced fusion and chromosome loss and 
translocation are prevented by culture conditions 
[3] the fusion product is a stable heterokaryon. 
Heterokaryons thus represent a stable and reprod- 
ucible model system for the study of biochemi- 
cal and molecular aspects responsible for muscle 
gene activation. Blau et al. [1], in fact, developed 
this fusion system in this direction: they esta- 
blished hybrids between differentiated muscle cells 
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(mouse myotubes) and non-muscle cells (human 
amniotic ells) and demonstrated that in these sta- 
ble fusion products, silent human genes were ac- 
tivated. This system also gave the possibility to 
study whether the products of this gene activation 
are spatially connected to the nuclei coming from 
the cell type containing the genetic information. 
Pavlath et al. [14] have reported that some struc- 
tural proteins (i.e. human myosin heavy chain and 
antigen 5.1Hll) and a Golgi apparatus enzyme 
(galactosyl transferase) are only expressed near the 
nucleus containing the genetic information. They 
called this restricted region of expression (I00 
g,m) a "nuclear domain". However, other authors 
[7, 12] using heterokaryons formed between dys- 
trophin negative and dystrophin positive fibers did 
not observe a restricted nuclear domain for dys- 
trophin in hybrid myotubes. 
Our main objective was to use the hybrid model 
to study the re-expression f a cytoplasmic activ- 
ity, namely glucose-6-phosphate dehydrogenase 
(G6PD), a widely distributed X-linked enzyme, in 
hybrid myotubes formed between G6PD-deficient 
and G6PD positive myoblasts. Even though ane- 
mia is the most frequent clinical manifestation f
GtPD deficiency, affecting 400 million people 
worldwide, a muscular form of this deficiency has 
been decribed [4]. We thus prepared cell cultures 
from muscle biopsy specimens of patients affect- 
ed by the G6PD Mediterranean variant, one of the 
most common, which has the advantage of ex- 
pressing the defect in vitro (compared to other 
variants where the enzymatic activity is not al- 
ways detectable) and the restoration of GtPD ac- 
tivity in this fusion system was examined in a 
variety of ways. The next step was elucidate the 
mechanisms underlying the restoration of this 
specific activity and apply the results obtained to 
the understanding of more complex mechanisms 
involved in muscle gene activation. 
Material and method 
The potential to restore a cytoplasmic activity li- 
Ice G6PD in hybrid myotubes formed between en- 
zyme deficient and normal cell types was inves- 
tigated in ~ variety of ways. The hybrid model 
proved to be a stable fusion system for studying 
the mechanisms involved in the restoration of 
G6PD activity in the fusion products obtained. 
Normal human myoblasts were obtained from 
muscle biopsy specimens from patients who were 
ultimately deemed to be free of muscle disease 
and G6PD-deficient human myoblasts were ob- 
tained from the patient muscle specimens with 
appropriate thical approval, Mass muscle cul- 
tures in pre-fusion (mononuclear cells) and post- 
fusion stages (myotubes) from normal and deft- 
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Fig. 1. Hybrid formation. 
.cient patients were established according to pre- 
viously described methods [10]. 
Human myoblasts were grown in proliferative 
medium (Muscle Medium: MM =Minimum Es- 
sential Medium - -  MEM - -  Earle's Salts en- 
riched with non-essential minoacids, pyruvate, 
vitamins in the presence of 75% Units/ml penicil- 
lin, 75 ug/ml streptomycin and 0.25 ug/ml am- 
photericin B) enriched with FCS 13%. 
Mouse myoblasts were obtained by a dissociation 
method using 15--16 day old fetal mouse muscle 
(HaM/ICR) as previously described. Wistar adult 
mice (80-120 gr.) obtained from Charles River 
Labs were used in all studies. 
Hybrid formation: about 25.000 G6PD-deficient 
human myoblasts were harvested and mixed with 
25.000 mouse myoblasts (grown in a specific 
medium: M199 added with CEE and HS 15%) or 
with 25.000 normal human myoblasts so that a 1:1 
ratio of normal myoblasts and G6PD-deficient 
myoblasts was obtained (Fig. 1). In other trials 
different ceU densities were used so that the nu- 
clear ratio in the hybrids formed couldbe more 
easily manipulated. The cell mixture was then 
plated on glass cover-sides in 24 mm multi-weU 
Costars. 
Hybrid myotubes were obtained by spontaneous 
fusion or by polyethylene glycol (PEG) induced 
fusion. PEG 1000 moL wt. was used; to prepare 
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Fig. 2. Fibroblasts reated with PEG 1000. a." mononucleated fibroblasts are present in a monolayer in the area 
examined BEFORE PEG treatment, b: same culture AFTER 1 minute treatment with PEG 1000. The cells were 
observed and photographed after 48 hours in culture with the appropriate medium. 
PEG solution, PEG was autoclaved and warm MM 
medium (without serum) was added to the warm 
PEG to obtain a 50% solution. The concentration 
of the PEG solution is expressed on a weight/ 
weighs basis, assuming that 1 ml of medium 
weights 1 gr. The fusion protocol adopted is as 
previously described [5]. A differentiation med- 
ium containing MEM with 5% HS [10] was then 
used and changed each day until hybrid forma- 
tion occurred. Histochemical nd biochemical an- 
alysis were then carded out. To demonstrate hat 
PEG actually induced fusion and that this did not 
affect he vitality of the cells in culture, fusion was 
PEG-induced in fbroblasts which normally do not 
form multinucleated cells (Fig. 2). 
G6PD staining: the histochemical reaction was 
performed on the patient muscle cultures, on nor- 
mal human and defcient myoblasts and myotubes 
and on the hybrid myotubes obtained. For a cy- 
tochemical demonstration f G6PD, muscle cul- 
tures were rinsed in Earle's balanced salt solution 
(EBSS), drained and air dried. The cells were then 
stained for G6PD activity by incubating for 50 
minutes at 37 ~ C, in a specific medium containing 
100 mM G6P, 1 mM MgC12, 0.6 mM Nitroblue 
Tetrazolium (NBT), 100 rag/10 ml polyvinylpyr- 
rolidone in 0.2 M "Iris buffer pH 7.8. Background 
reaction was performed without substrate G6P. 
G6PD histochemical ctivity was observed with 
Zeiss microscope. G6PD staining was compared 
in short- and long-term cultures to evaluate the ti- 
me-course of this enzymatic activity. 
Hoechst 33258 staining: (Sigma, St-Louis, USA). 
This is a DNA m specific dye used to distinguish 
the hybrid myotubes formed between human and 
mouse myoblasts according to their fluorescent 
pattern: the human nuclei were smooth and the 
mouse nuclei were dotted. 
When enough myotubes were present (more than 
100), the cultures were stained for 10 minutes with 
Hoechst (10 Ixg/ml). Then a coverslip was placed 
over a thin layer of 50% glycerol solution. 
Biochemical investigation: for biochemical inves- 
tigation, cultures were rinsed with cold 10 IxM 
NADP buffer and harvested by trypsinization. The 
enzymatic assays were performed spectrophoto- 
metrically on cell suspensions according to the 
described method [ 11 ]. 
Fluorescent Latex Microspheres (FLM): it is pos- 
sible to verify the formation of hybrid myotubes 
between G6PD,deficient and normal human 
myoblasts using Fluorescent Latex Microspheres 
(FLM) (Luma Fluor, New City, New York). Two 
types of microspheres (rhodamine and fluorescein 
spheres) were incorporated in the two different 
myogenic ell lines for 12 hours at a dilution of 
1:2500 in Muscle Medium enriched with 5% FCS. 
Cells from the two myogenic ell lines were then 
mixed at a ratio of 1:1 and grown in a differen- 
tiating medium (M199 +5% HS, penicillin, strep- 
tomycin and glutamine). Cell cultures were then 
observed with a fluorescent microscope until my- 
otube formation occurred. The formation of hy- 
brid myotubes was demonstrated by the presence 
of both types of microspheres within the same 
myotube [9]. 
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Fig. 3. The use of Hoechst stain to distinguish human from murine nuclei, a: Hoechst stain gives a dotted ap- 
pearance to the murine nucleus (arrow); human nuclei instead (4 in the picture) appear uniformly stabled, b: 
same myotube #1 phase-contrast microscopy. 
Fig. 4. Fluorescent latex microspheres (FLMs). a: rhodamine and b: fluorescine coloured myotube after 5 weeks 
in culture, c: rhodamine and d: fluorescine myotube after 6 weeks in culture. 
Results 
Our first objective was to optimize cellular fusion 
using PEG and to identify hybrid formation by the 
use of different methods. PEG actually proved to 
act on cell membranes because treatment on nor- 
mally mononucleate c lls (fibroblasts) just like 
treatment on myoblasts effectively induced fusion 
in the fibroblasts tested for control (Fig. 2A and 
2B). Moreover it did not seem to affect the via- 
bility of the cells in culture and histochemical nd 
staining reactions could be carried out as u~ual. 
Similar results were obtained in hybrids produced 
by spontaneous and PEG-induced fusion. 
The first identification method using Hoechst stain 
proved to be quite effective in distinguishing 
mouse and human nuclei because, as has been 
previously demonstrated [14], mouse nuclei ap- 
pear dotted compared to the uniform distribution 
of the stain in human nuclei (Fig. 3A and 3B). 
However this method has the disadvantage that it 
implies fixation. Different nuclear atios were ob- 
tained in the human-mouse hybrids formed but 
this did not appear to be connected to the cell 
densities used because the nuclei predominating 
in the hybrid formed were not necessarily the ones 
belonging to the cell type plated at higher densi- 
ties. By varying the densities at which mixture 
occurred hybrid myotubes were also obtained at 
ratios other than 1:1. 
The second identification method using Fluores- 
cent Latex Microspheres (FLM) of different co- 
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Fig. 5. G6PD activity in long-term cultures, a: G6PD granules can be seen uniformly distributed throughout he 
human-human hybrid myotube after 8 weeks in culture (arrows). b: similar granular appearance after 9 weeks in 
culture (arrows) in a human-human hybrid myotube. 
Fig. 6. G6PD-deficient human myotube. Note the de. 
crease in the number and distribution (arrows) of G6PD 
granules throughout the myotube. 
lors has the advantage that the presence of a hy- 
brid myotube can be detected in a living culture 
by observation with a fluorescent microscope but 
has the disadvantage that the position and the 
identification of the competent uclei cannot be 
recognized. Our results confirmed that these flu- 
orescent latex microspheres do not affect fusion, 
proliferation or viability of the cells in culture [9]. 
We were also able to observe fluorescence easily 
after 5 or 6 weeks in culture (Fig. 4A and 4B and 
4C and 4D respectively). It was then also possi- 
ble to test for G6PD activity in long-term cultures 
(up to 8-9 weeks in culture) to verify the stability 
of the specific restoration and demonstrate that this 
fusion system also has the advantage that the ex- 
perimental investigations can be carried out in vi- 
tro in long-term cultures (Fig. 5A and 5B). 
The next step was to evaluate G6PD activity in 
the myotubes obtained from our patients. In con- 
firmation of our previous observations [4] the de- 
fect in the Mediterranean variant is expressed in 
vitro (Fig. 6). Our main objective here was to 
verify whether there was a correction of this lack 
of enzymatic activity in the hybrid myotubes. Our 
results indicate that there is a restoration of G6PD 
activity in the hybrid myotubes (Fig. 7A) formed 
spontaneously between ormal and G6PD-defi- 
cient human (Fig. 6) myoblasts and between or- 
mal murine and G6FD-deficient myoblasts (Fig. 
6). Similar results were also obtained following 
PEG induced fusion. 
In all hybrid myotubes obtained, G6PD granules 
reappeared throughout the cytoplasm although this 
activity was less pronounced in human-mouse 
hybrid myotubes (Fig. 8A) than in human-human 
hybrids (Fig. 7A). 
Human-human hybrid formation was confirmed by 
the presence of both types of microspheres within 
the same myotube (Fig. 7B and 7C) and human- 
mouse hybrid formation by the presence of dotted 
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Fig. 7. G6PD deficient- normal human hybrid myotubes, a.- restoration of G6PD activity in the human-human 
hybrid myotube obtained by spontaneous fusion (2 weeks in culture). This hybrid myotube was formed by the fu- 
sion of norma ! human myoblusts (labelled with rhodamine FLMs) and G6PD deficient human myoblasts (labelled 
with fluorescein FLMs). The same hybrid rayotabe as in a observed with a fluorescent microscope and tested for 
the presence of flnorescein (b) and rhodamine (c) microspheres to confirm hybrid formation. The arrows indicate 
the presence of both types of FLMs in the same region of the myotube. 
and uniformly stained nuclei using Hoechst stain 
in the same myotube (SB); Hoechst staining was 
employed to verify whether restoration of enzy- 
matic activity was dependent on the position of the 
competent nucleus, as has been previously des- 
cribed in muscle-non muscle heterokaryons [3, 
13]. Our data clearly indicate that he re-expression 
40 
of enzymatic activity is independent of the posi- 
tion of"competent" nuclei (Figure 9A, 9B, 9C and 
9D). In all human-mouse hybrid myotubes ob- 
tained G6PD activity appears uniformly distri- 
buted throughout the cytoplasm, irrespective of 
diffea, ent nuclear atios. G6PD staining did not in- 
terfere with any of the identification methods used. 
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Fig, 8, Hybrid myotube formed by human G6PD-deficient and murine myoblasts, a: human-mouse hybrid my- 
otube: the restoration of diffuse enzymatic activity (arrow) is clearly evident. The same myotube observed after 
Hoechst staining in b to confirm hybrid formation: note the presence of I routine dotted nucleus (arrow) and 3 
human uclei (smooth appearance). 
Discussion 
Heterokaryon experiments suggested that the pro- 
cess of cell specialization is not fixed, i.e. heter- 
okaryon facilitate "genetic approach" to the iso- 
lation of the genes encoding factors that intervene 
at different steps in the muscle regulatory hierar- 
chy [2]. 
Activation was detected for genes encoding dif- 
ferent muscle functions: an enzyme creatine-kin- 
Fig. 9. Evaluation of G6PD activity in hybrid myotubes formed between G6PD-deficient and murine myoblasts. 
a: myotube observed after Hoechst staining showing 2 routine nuclei (arrows) and 26 human nuclei and b after 
G6PD staining after 2 weeks in culture. Notice the initial distribution of enzymatic activity (arrows) in this large 
myotube. 
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Fig. 9. C: myotube with 1 mUrine nucleus farrow) and 6. human nuclei, d: the same myotube in. which G6PD 
granules are seen throughout the myotube (arrows). Note the restoration of G6PD activity is independent of the 
position of the competent uclei. 
ase; two cell-surface antigens 51Hll and 24ID5 
and components of the contractile apparatus 
myosin light-chains, myosin heavy-chains, ar- 
cometic actin transcript. All these previous exper- 
iments confirmed the plasticity of the differentiat- 
ed state of: muscle where genes are switched on 
and off giving rise to different phenotypes. 
This is, to our knowledge, the first application of 
a heterokaryon system formed between G6PD-ne- 
gative and G6PD-positive myobtasts in the at- 
tempt to restore the enzymatic activity in the 
newly-formed myotubes. 
The identification methods used to recognize hy- 
brid myotubes, proved to be extremely effective 
essentially because it was possible to obtain dif- 
ferent information. FLMs were used not only to 
identify hybrids but also to test for G6PD activity 
in long-term cultures. In fact the detectability of
both colored microspheres after 6 weeks in cul- 
ture allowed us to obtain data concerning the ti- 
me-course of this enzymatic activity in the hybrid 
myotubes formed: G6PD granules can still be de- 
tected after 8 and 9 weeks in culture throughout 
the cytoplasm; this is important because this hy- 
brid model proves to be an adequate in vitro sys- 
tem for studying cytoplasmic a tivities like G6PD. 
Hoechst stain instead enabled us to evaluate 
whether diffusible molecules that are transported 
through the cytoplasm, mediate the activation of 
genes observed in beterokaryons, since the nuclei 
of the two cell types remain separate and distinct. 
Results obtained using Hoechst stain indicate that 
regardless of the number and position of the 
"competent" nuclei, the distribution of granules 
was similar in all hybrid myotubes observed. One 
normal nucleus is sufficient to restore nzymatic 
activity throughout the hybrid myotube and gran- 
des are detected throughout the cytoplasm and not 
only in the area immediately surrounding the 
competent ucleus. This suggests that G6PD re- 
expression could be due to a "passive" distribu- 
tion of enzyme activity throughout the hybrid 
myotube formed. 
This experimental model thus proves to be an ad- 
equate one for studying the expression of this en- 
zymatic activity because: i) the defect is ex- 
pressed in vitro; ii) it is corrected in all hybrid 
myotubes obtained and iii) the restoration is 
maintained in long-term cultures. This not only 
provides the scientific background for myoblast 
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transfer therapy but suggests that the correction 
obtained when competent and deficient nuclei n- 
termingle in the cytoplasm of heterokaryons is not 
a transitory event. The restoration of G6PD activ- 
ity demonstrates that this fusion system proves to 
be an adequate xperimental model not only for 
elucidating the specific mechanisms involved in 
G6PD re-expression but also for clarifying the 
molecular aspects of regulation of gene expres- 
sion. 
Sommario 
II modello degli ibridi costituisce un sistema valido e riproducibile per studiare gli aspetti biochimici 
e molecolari implicati nell'attivazione genica. Tale sistema di fusione ~ stato utilizzato da precedenti 
autori per dimostrare l'attivazione di specifici geni umani in ibridi format! dalla fusione di cellule umane 
con cellule non-umane. Lo scopo di questa ricerca ~ stato quello di applicare il modello sperimentale 
degli ibridi per valutare la correzione di un'attivit?t citoplasmatica, quale la glucosio-6-fosfato deidro- 
genasi (G6PD), in vitro, in ibridi formati tra mioblasti G6PD-deficitari e normali. Sono stati impiegati 
diverse metodiche per identificare i miotubi bridi (colorante nucleo-specifico, Hoechst e microsfere di 
lattice fluorescinate  rodaminate). I nostri risultati ndicano che vi ~ un ripristino dell'attivit~ G6PD 
in tutti i miotubi ibridi formati; abbiamo quindi tentato di comprendere i meccanismi specifici sotto- 
stanti alia ricomparsa di quest'attivit~ enzimatica per poterli applicare alia comprensione dei pif~ 
complessi meccanismi implicati nell'attivazione di geni muscolari. 
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